The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.
Ontology highlight
ABSTRACT: During tumor growth and angiogenesis there is a dynamic remodeling of tissue architecture often accompanied by the release of extracellular matrix constituents full of biological activity. One of the key constituents of the tumor microenvironment is the large heparan sulfate proteoglycan perlecan. This proteoglycan, strategically located at cell surfaces and within basement membranes, is a well-defined pro-angiogenic molecule when intact. However, when partially processed by proteases released during cancer remodeling and invasion, the C-terminal fragment of perlecan, known as endorepellin, has opposite effects than its parent molecule. Endorepellin is a potent inhibitor of angiogenesis by exerting a dual receptor antagonism by simultaneously engaging VEGFR2 and α2β1 integrin. Signaling th
SUBMITTER: Douglass S
PROVIDER: S-EPMC4769797 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
ACCESS DATA